Fig. 1From: Abstracts of 11th C1-inhibitor Deficiency & Angioedema WorkshopSimulations of steady-state complement component 1 (C1)-esterase inhibitor functional activity (C1-INH[f]) and observed C1-INH(f) concentrations following the administration of subcutaneous (SC) C1-INH at a 40 IU/kg and b 60 IU/kg doses in the COMPACT open-label extension studyBack to article page